Alport syndrome: a genomic to bear in mind

Descripción del Articulo

Introduction. Alport syndrome is a heterozygous alteration that affects the alpha chains of type IV collagen, manifesting itself clinically in a variable manner, mainly by persistent hematuria. There are different clinical manifestations in this pathology, fnding cases of chronic renal disease. It i...

Descripción completa

Detalles Bibliográficos
Autores: Rivero Rodriguez, Wilmer, Camelo Pardo, Gianmarco, González, Cesar Augusto, Gamboa Daza, Johan Abner
Formato: artículo
Fecha de Publicación:2022
Institución:Universidad de Huánuco
Repositorio:Revistas - Universidad de Huánuco
Lenguaje:español
OAI Identifier:oai:ojs2.localhost:article/220
Enlace del recurso:http://revistas.udh.edu.pe/index.php/RPCS/article/view/373e
Nivel de acceso:acceso abierto
Materia:nefritis hereditaria
insuficiencia renal
diagnostico
sistema renina-angiotensina
hereditary nephritis
renal failure
diagnosis
renin-angiotensin system
nefrite hereditária
insuficiência renal
diagnóstico
Descripción
Sumario:Introduction. Alport syndrome is a heterozygous alteration that affects the alpha chains of type IV collagen, manifesting itself clinically in a variable manner, mainly by persistent hematuria. There are different clinical manifestations in this pathology, fnding cases of chronic renal disease. It is crucial to establish measures that allow timely detection, thus reducing complications. Objective. To describe the relationship and importance between Alport syndrome and renal alterations, highlight the clinical manifestations and therapeutic management. Methods. A literature search was performed in PubMed and Scielo databases oriented towards updated and relevant articles in English or Spanish published in the last 5 years. The relationship betweenAlport syndrome and renal pathology was evaluated to describe clinicalsignifcance, diagnosis and treatment. Results. Different studies show a direct relationship between Alport syndrome and renal dysfunction associated with chronic inflammatory processes. The treatment is not standardized, but is aimed at blocking the renin-angiotensin-aldosterone system. Studies should continue to evaluate the outcome of renal involvement associated with this pathology. Conclusions. Alport syndrome is an important cause of renal dysfunction, especially if it is not associated with treatment; therefore, it is important to make a timely diagnosis through initial suspicion, differential diagnosis and appropriate approach based on the clinical recognition of this entity associated with the deterioration of renal function.
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).